Rac1 inhibits apoptosis in p53-deficient lymphoma cells by stimulating B-cell lymphoma 2 (Bcl-2)-associated death promoter (Bad) phosphorylation at Ser75 via protein kinase A and not protein kinase B in response to DNA-damaging chemotherapies [17]. Here, RAC1 is linked to lymphoma.